Hospitals are struggling to deal with an overwhelming number of cases of diseases that result from intravenous opioid use, including hepatitis C, endocarditis and the antibiotic-resistant infection MRSA.
Hepatitis C is the most common infectious disease that affects people with opioid use disorder, USA Today reports.
Reported cases of the disease almost tripled between 2010 and 2015.
Endocarditis—a condition in which the heart’s inner lining is inflamed—is a side effect of opioid addiction. Hospitalizations for endocarditis rose almost 50 percent from 2002 to 2012, at an average cost of $50,000 per patient.
MRSA is the second most common co-occurring condition with opioid use disorder, the article notes. The cost of treating the infection is about $60,000 per patient.
- Teens Bring Juul E-Cigarette Device, Which Looks Like USB Flash Drive, to School
- NIAAA Alcohol Treatment Navigator: Pointing the Way to Quality Care
- DEA Collects Record Number Of Unused Pills As Part Of Its 14th Prescription Drug Take Back Day
- NIDA Launches Two Adolescent Substance Use Screening Tools
- Patients Treated with Naloxone Continue to be at High Risk of Overdose: Study
- New Rule Allows Health Providers to Share Information about Overdose with Family
- Addressing the Opioid Crisis Means Confronting Socioeconomic Disparities
- Drug Use Disorder vs. Drug Misuse - What is the Difference?
- NCADD Affiliate Executive Director Featured in NY Times Op Ed
- President’s Commission on Opioid Crisis Calls for Nationwide System of Drug Courts
- Fentanyl is Key Factor Driving Opioid Overdose Deaths: CDC
- Many Teens Who Take Adderall as “Study Drug” Unaware it is Amphetamine
- Giving Tuesday
- Drug Overdose Death Rates in Rural Areas Exceed Those in Cities
- FDA Encourages Use of Medication-Assisted Treatment for Opioid Addiction
- DEA releases 2017 National Drug Threat Assessment
- President’s Opioid Commission Focuses on Insurance Companies’ Role in Crisis
- Smoking Marijuana and Driving
- National Prevention Week 2018
- Statement from The NIH Director on Combating the Opioid Crisis with Scientific Solutions